Grant C. Bogle

CIK 1646675 · President and CEO · last filed 2025-06-20

Grant C. Bogle is a President and CEO who has filed 16 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for NUVL, was dated Jun 20, 2025. Across all open-market trades the lifetime net is −$2.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $720.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$720.6K

Companies

3

Total Filings

16

Lifetime Open-Market Net

-$2.27M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NUVL Director 5,847 $123.25 $720.6K $0 2 2025-06-20
Epizyme, Inc. (EPZM) Delisted See Remarks 259,170 $1.47 $381.0K $0 7 2022-08-11
TESARO, Inc. (TSRO) Delisted Sr. VP, Chief Commercial Ofc 0 -$2.27M 6 2019-01-22

Recent Filings

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-06-20 NUVL Grant (A) +2,647 $0 EDGAR
2024-12-09 NUVL Grant (A) +3,200 $0 EDGAR
2022-08-16 Disp (D) −259,170 $0
2022-08-11 Epizyme, Inc. (EPZM) Delisted Mixed +76,110 $106.2K EDGAR
2022-03-21 Epizyme, Inc. (EPZM) Delisted Grant (A) $0 EDGAR
2022-02-04 Epizyme, Inc. (EPZM) Delisted Grant (A) +87,500 $0 EDGAR
2021-08-18 Epizyme, Inc. (EPZM) Delisted Grant (A) +87,500 $0 EDGAR
2021-06-15 Epizyme, Inc. (EPZM) Delisted Grant (A) +8,060 $0 EDGAR
2020-06-02 Epizyme, Inc. (EPZM) Delisted Grant (A) $0 EDGAR
2019-09-04 Epizyme, Inc. (EPZM) Delisted Grant (A) $0 EDGAR
Showing 110 of 16
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.